Cat.#: ACPP-1354
| Despition | PAX2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1667 | Human AGRP Protein (AC1667) | 2 µg | inquiry |
| ACPP-1071 | Visfatin Blocking Peptide (AC1071) | 250 µg | inquiry |
| ACPP-1378 | Human EFNB3 Protein (AC1378) | 5 µg | inquiry |
| ACPP-1127 | Recombinant Human alpha Synuclein Protein (AC1127) | 50 µl | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
| ACPP-1497 | Human AMIGO2 Protein (AC1497) | 2 µg | inquiry |
| ACPP-1267 | Acrp30 Mouse, Trimeric (AC1267) | 2 µg | inquiry |
| ACPP-1824 | Human HOMER2 Protein (AC1824) | 2 µg | inquiry |
| ACPP-1818 | Mouse FGF 9 Protein (AC1818) | 2 µg | inquiry |
| ACPP-1506 | Human NDE1 Protein (AC1506) | 5 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.